The most common drug-related grade 3 laboratory toxicities ( graded according to Common Terminology for Adverse Events [ version 3.0 ] ) were thrombocytopenia ( 18.9 % ) for patients treated with tasisulam and neutropenia/leukopenia ( 8.7 % ) among those receiving paclitaxel .